Solid Biosciences: Strategic Advancements and Promising Pipeline Justify Buy Rating
Leerink Partners analyst Joseph Schwartz has maintained their bullish stance on SLDB stock, giving a Buy rating yesterday.Stay Ahead of the ...
manilatimes3d
FRED'S TEAM RAISES OVER $8.5 MILLION FOR CANCER RESEARCH IN RECORD-BREAKING YEAR
A Fred's Team runner greets supporters during the 2024 TCS New York City Marathon. 100% of the money raised through Fred's Team goes directly to cancer research at Memorial Sloan Kettering Cancer ...